{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T07:48:40Z","timestamp":1794210520125,"version":"4.8.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T00:00:00Z","timestamp":1620604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T00:00:00Z","timestamp":1620604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["4688\/2-1"],"award-info":[{"award-number":["4688\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Rare and severe neurological disorders in childhood not only heavily affect the life perspective of the patients, but also their caregivers and families. The aim of this study was to investigate the impact of such diseases on the family, especially on the quality of life and life perspectives of parents, but also on the families\u2019 everyday life, based on the model of two diseases which have been well described in recent years with respect to symptoms and course: metachromatic leukodystrophy (MLD) and pontocerebellar hypoplasia type 2 (PCH2). PCH2 is a primary severe developmental disorder, while children with MLD initially develop normally and then progressively deteriorate.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Using a semi-standardized questionnaire, 43 families with children suffering from MLD (n\u2009=\u200930) or PCH2 (n\u2009=\u200919) reported data on the severity of the illness\/symptoms, on family support and the care situation, as well as on the circumstances of non-affected siblings and the parents\u2019 work situation. In addition, the quality of life of parents and general family functioning was assessed using the PedsQL\u2122 Family Impact Module [23]. Results for the latter were compared to published data from families with children without any chronic condition using student\u2019s t-tests for independent samples. Potential factors influencing the PedsQL\u2122 scores were analyzed using Spearman\u2019s rank correlation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Parents of children with MLD and PCH2 reported significantly lower health-related quality of life (HRQOL) compared to parents of healthy children (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Mothers showed significantly poorer HRQOL (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) and were significantly more dissatisfied with their professional development (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) than fathers, and this was seen in relation to their child's disease. Neither the form of disease (\u2018primary\u2019 symptomatic PCH2 or \u2018secondary\u2019 symptomatic MLD), nor the severity of the child\u2019s illness (in terms of gross motor and speech function) had a specific impact on HRQOL in families. However, the time from diagnosis and advanced symptoms in the terminal disease stage were experienced as especially distressing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study illustrates that MLD and PCH2 affect mothers in particular, but also the entire family. This underlines the need for personalized care and counselling of parents and families, especially following diagnosis and during the end stage in a child with a severe, rare chronic neurological disorder.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13023-021-01828-y","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T12:03:21Z","timestamp":1620648201000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["The impact of severe rare chronic neurological disease in childhood on the quality of life of families\u2014a study on MLD and PCH2"],"prefix":"10.1186","volume":"16","author":[{"given":"Louisa","family":"Ammann-Schnell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2706-7163","authenticated-orcid":false,"given":"Samuel","family":"Groeschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Kehrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Fr\u00f6lich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Kr\u00e4geloh-Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,10]]},"reference":[{"key":"1828_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1177\/0269216310391346","volume":"25","author":"C Malcolm","year":"2011","unstructured":"Malcolm C, Forbat L, Anderson G, Gibson F, Hain R. Challenging symptom profiles of life-limiting conditions in children: a survey of care professionals and families. Palliat Med. 2011;25:357\u201364.","journal-title":"Palliat Med"},{"key":"1828_CR2","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/j.1651-2227.2012.02680.x","volume":"101","author":"C Malcolm","year":"2012","unstructured":"Malcolm C, Hain R, Gibson F, Adams S, Anderson G, Forbat L. Challenging symptoms in children with rare life-limiting conditions: findings from a prospective diary and interview study with families: Challenging symptoms in rare LLCs. Acta Paediatr. 2012;101:985\u201392.","journal-title":"Acta Paediatr"},{"key":"1828_CR3","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1177\/0883073816656401","volume":"31","author":"FS Eichler","year":"2016","unstructured":"Eichler FS, Cox TM, Crombez E, Dali C\u00cd, Kohlsch\u00fctter A. Metachromatic Leukodystrophy: An Assessment of Disease Burden. J Child Neurol. 2016;31:1457\u201363.","journal-title":"J Child Neurol"},{"key":"1828_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/8904_2018_119","volume":"44","author":"T Conijn","year":"2019","unstructured":"Conijn T, Nijmeijer SCM, van Oers HA, Wijburg FA, Haverman L. Psychosocial Functioning in Parents of MPS III Patients. JIMD Rep. 2019;44:33\u201341.","journal-title":"JIMD Rep"},{"key":"1828_CR5","doi-asserted-by":"crossref","unstructured":"Gainotti S, Mascalzoni D, Bros-Facer V, Petrini C, Floridia G, Roos M, et al. Meeting patients\u2019 right to the correct diagnosis: ongoing international initiatives on undiagnosed rare diseases and ethical and social issues. Int J Environ Res Public Health [Internet]. 2018 [cited 2021 Feb 7];15. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6210164\/.","DOI":"10.3390\/ijerph15102072"},{"key":"1828_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/hsw\/25.1.59","volume":"25","author":"RI Freedman","year":"2000","unstructured":"Freedman RI, Boyer NC. The Power to Choose: Supports for Families Caring for Individuals with Developmental Disabilities. Health Soc Work. 2000;25:59\u201368.","journal-title":"Health Soc Work"},{"key":"1828_CR7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1177\/1367493513496668","volume":"18","author":"J Hatzmann","year":"2014","unstructured":"Hatzmann J, Peek N, Heymans H, Maurice-Stam H, Grootenhuis M. Consequences of caring for a child with a chronic disease: employment and leisure time of parents. J Child Health Care. 2014;18:346\u201357.","journal-title":"J Child Health Care"},{"key":"1828_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3233\/PRM-150321","volume":"8","author":"SA Johaningsmeir","year":"2015","unstructured":"Johaningsmeir SA, Colby H, Krauthoefer M, Simpson P, Concei\u00e7\u00e3o SCO, Gordon JB. Impact of caring for children with medical complexity and high resource use on family quality of life. J Pediatr Rehabil Med. 2015;8:75\u201382.","journal-title":"J Pediatr Rehabil Med"},{"key":"1828_CR9","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1212\/WNL.0000000000011047","volume":"96","author":"C Kehrer","year":"2021","unstructured":"Kehrer C, Elg\u00fcn S, Raabe C, B\u00f6hringer J, Beck-W\u00f6dl S, Bevot A, et al. Association of age at onset and first symptoms with disease progression in patients with metachromatic leukodystrophy. Neurology. 2021;96:e255\u201366.","journal-title":"Neurology"},{"key":"1828_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1750-1172-9-70","volume":"9","author":"I S\u00e1nchez-Albisua","year":"2014","unstructured":"S\u00e1nchez-Albisua I, Fr\u00f6lich S, Barth PG, Steinlin M, Kr\u00e4geloh-Mann I. Natural course of pontocerebellar hypoplasia type 2A. Orphanet J Rare Dis. 2014;9:70.","journal-title":"Orphanet J Rare Dis"},{"key":"1828_CR11","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/(SICI)1096-8628(19970905)71:4<475::AID-AJMG20>3.0.CO;2-C","volume":"71","author":"P Heim","year":"1997","unstructured":"Heim P, Claussen M, Hoffmann B, Conzelmann E, G\u00e4rtner J, Harzer K, et al. Leukodystrophy incidence in Germany. Am J Med Genet. 1997;71:475\u20138.","journal-title":"Am J Med Genet"},{"key":"1828_CR12","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1203\/00006450-197910000-00021","volume":"13","author":"LJ Shapiro","year":"1979","unstructured":"Shapiro LJ, Aleck KA, Kaback MM, Itabashi H, Desnick RJ, Brand N, et al. Metachromatic leukodystrophy without arylsulfatase A deficiency. Pediatr Res. 1979;13:1179\u201381.","journal-title":"Pediatr Res"},{"key":"1828_CR13","unstructured":"Gieselmann V, Kr\u00e4geloh-Mann I. Metachromatic Leukodystrophy. In: Valle D, Beaudet A, Vogelstein D, Kinzler K, Antonarakis S, Ballabio A, et al., editors. The online metabolic and molecular bases of inherited disease [Internet]. New York: McGraw-Hill; 2014. p. chapter 148. http:\/\/ommbid.mhmedical.com\/book.aspx?bookid=971."},{"key":"1828_CR14","doi-asserted-by":"crossref","unstructured":"Kehrer C, Blumenstock G, Gieselmann V, Kr\u00e4geloh-Mann I, ON BEHALF OF THE GERMAN LEUKONET. The natural course of gross motor deterioration in metachromatic leukodystrophy: Gross Motor Deterioration in Metachromatic Leukodystrophy. Developmental Medicine & Child Neurology. 2011;53:850\u20135.","DOI":"10.1111\/j.1469-8749.2011.04028.x"},{"issue":"Suppl 3","key":"1828_CR15","doi-asserted-by":"publisher","first-page":"S257","DOI":"10.1007\/s10545-010-9140-4","volume":"33","author":"O Artigal\u00e1s","year":"2010","unstructured":"Artigal\u00e1s O, Lagranha VL, Saraiva-Pereira ML, Burin MG, Louren\u00e7o CM, van der Linden H, et al. Clinical and biochemical study of 29 Brazilian patients with metachromatic leukodystrophy. J Inherit Metab Dis. 2010;33(Suppl 3):S257-262.","journal-title":"J Inherit Metab Dis"},{"key":"1828_CR16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.1469-8749.2010.03821.x","volume":"53","author":"C Kehrer","year":"2011","unstructured":"Kehrer C, Blumenstock G, Raabe C, Kr\u00e4geloh-Mann I. Development and reliability of a classification system for gross motor function in children with metachromatic leucodystrophy. Dev Med Child Neurol. 2011;53:156\u201360.","journal-title":"Dev Med Child Neurol"},{"key":"1828_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1750-1172-9-18","volume":"9","author":"C Kehrer","year":"2014","unstructured":"Kehrer C, Groeschel S, Kustermann-Kuhn B, B\u00fcrger F, K\u00f6hler W, Kohlsch\u00fctter A, et al. Language and cognition in children with metachromatic leukodystrophy: onset and natural course in a nationwide cohort. Orphanet J Rare Dis. 2014;9:18.","journal-title":"Orphanet J Rare Dis"},{"key":"1828_CR18","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1001\/jamaneurol.2016.2067","volume":"73","author":"S Groeschel","year":"2016","unstructured":"Groeschel S, K\u00fchl J-S, Bley AE, Kehrer C, Weschke B, D\u00f6ring M, et al. Long-term outcome of allogeneic hematopoietic stem cell transplantation in patients with juvenile metachromatic leukodystrophy compared with nontransplanted control patients. JAMA Neurol. 2016;73:1133.","journal-title":"JAMA Neurol"},{"key":"1828_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00401-007-0263-0","volume":"114","author":"PG Barth","year":"2007","unstructured":"Barth PG, Aronica E, de Vries L, Nikkels PGJ, Scheper W, Hoozemans JJ, et al. Pontocerebellar hypoplasia type 2: a neuropathological update. Acta Neuropathol. 2007;114:373\u201386.","journal-title":"Acta Neuropathol"},{"key":"1828_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1750-1172-6-50","volume":"6","author":"Y Namavar","year":"2011","unstructured":"Namavar Y, Barth PG, Poll-The B, Baas F. Classification, diagnosis and potential mechanisms in Pontocerebellar Hypoplasia. Orphanet J Rare Dis. 2011;6:50.","journal-title":"Orphanet J Rare Dis"},{"key":"1828_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/brain\/awq287","volume":"134","author":"Y Namavar","year":"2011","unstructured":"Namavar Y, Barth PG, Kasher PR, van Ruissen F, Brockmann K, Bernert G, et al. Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia. Brain. 2011;134:143\u201356.","journal-title":"Brain"},{"key":"1828_CR22","doi-asserted-by":"crossref","unstructured":"O\u2019 Brien I, Duffy A, Nicholl H. Impact of childhood chronic illnesses on siblings: a literature review. Br J Nurs. 2009;18:1358, 1360\u20135.","DOI":"10.12968\/bjon.2009.18.22.45562"},{"key":"1828_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1477-7525-2-55","volume":"2","author":"JW Varni","year":"2004","unstructured":"Varni JW, Sherman SA, Burwinkle TM, Dickinson PE, Dixon P. The PedsQLTM family impact module: preliminary reliability and validity. Health Qual Life Outcomes. 2004;2:55.","journal-title":"Health Qual Life Outcomes"},{"key":"1828_CR24","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1016\/j.ridd.2013.06.035","volume":"34","author":"L Pennington","year":"2013","unstructured":"Pennington L, Virella D, Mj\u00f8en T, da Gra\u00e7a AM, Murray J, Colver A, et al. Development of The Viking Speech Scale to classify the speech of children with cerebral palsy. Res Dev Disabil. 2013;34:3202\u201310.","journal-title":"Res Dev Disabil"},{"key":"1828_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1023\/B:QURE.0000015305.44181.e3","volume":"13","author":"R Felder-Puig","year":"2004","unstructured":"Felder-Puig R, Frey E, Proksch K, Varni JW, Gadner H, Topf R. Validation of the German version of the Pediatric Quality of Life Inventory (PedsQL) in childhood cancer patients off treatment and children with epilepsy. Qual Life Res. 2004;13:223\u201334.","journal-title":"Qual Life Res"},{"key":"1828_CR26","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1007\/s11136-013-0422-9","volume":"22","author":"GR Medrano","year":"2013","unstructured":"Medrano GR, Berlin KS, Hobart DW. Utility of the PedsQLTM family impact module: assessing the psychometric properties in a community sample. Qual Life Res. 2013;22:2899\u2013907.","journal-title":"Qual Life Res"},{"key":"1828_CR27","unstructured":"Pflegegrade [Internet]. [cited 2019 Oct 20]. https:\/\/www.bundesgesundheitsministerium.de\/pflegegrade.html#c4793."},{"key":"1828_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s41687-019-0140-3","author":"M Harrington","year":"2019","unstructured":"Harrington M, Hareendran A, Skalicky A, Wilson H, Clark M, Mikl J. Assessing the impact on caregivers caring for patients with rare pediatric lysosomal storage diseases: development of the Caregiver Impact Questionnaire. J Patient Rep Outcomes. 2019. https:\/\/doi.org\/10.1186\/s41687-019-0140-3.","journal-title":"J Patient Rep Outcomes"},{"key":"1828_CR29","unstructured":"Burton L. The family life of sick children: a study of families coping with chronic childhood disease. London\u202f; Boston: Routledge and K. Paul; 1975."},{"key":"1828_CR30","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1515\/jpem-2018-0056","volume":"31","author":"S Shalitin","year":"2018","unstructured":"Shalitin S, Hershtik E, Phillip M, Gavan M-Y, Cinamon RG. Impact of childhood type 1 diabetes on maternal work-family relations. J Pediatr Endocrinol Metab. 2018;31:569\u201376.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"1828_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1300\/J006v18n01_01","volume":"18","author":"P Rosenbaum","year":"1998","unstructured":"Rosenbaum P, King S, Law M, King G, Evans J. Family-Centred Service: A Conceptual Framework and Research Review. Phys Occup Ther Pediatr. 1998;18:1\u201320.","journal-title":"Phys Occup Ther Pediatr"},{"key":"1828_CR32","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1469-8749.2011.04068.x","volume":"53","author":"P Rosenbaum","year":"2011","unstructured":"Rosenbaum P. Family and quality of life: key elements in intervention in children with cerebral palsy: Review. Dev Med Child Neurol. 2011;53:68\u201370.","journal-title":"Dev Med Child Neurol"},{"key":"1828_CR33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/13668250902874608","volume":"34","author":"K Davis","year":"2009","unstructured":"Davis K, Gavidia-Payne S. The impact of child, family, and professional support characteristics on the quality of life in families of young children with disabilities. J Intellect Dev Disabil. 2009;34:153\u201362.","journal-title":"J Intellect Dev Disabil"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01828-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-01828-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01828-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T22:12:29Z","timestamp":1672092749000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-01828-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,10]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1828"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-01828-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,10]]},"assertion":[{"value":"6 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Faculty of Medicine of the University of T\u00fcbingen approved this study on 7\/13\/2016 (Project Number 402\/2016BO2). All parents included in the study had signed the consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.SG received institutional research support from Shire plc, outside of the submitted work. He is advisor and co-investigator for trials in Metachromatic Leukodystrophy (Shire\/Takeda, Orchard, Homology Medicine), but receives no personal payment related to this role.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"211"}}